White label ELPA - ClinicalTrials.eu

Study on the Effect of Ketamine and Esketamine in Patients with Major Depressive Disorder After First-Line Treatment Failure

Recruiting

3 1 1 1
Investigated diseases:
- Major depression
Investigated drugs:
Study on the Effects of Avalglucosidase Alfa Enzyme Replacement Therapy in Patients with Pompe Disease

Recruiting

3 1 1 1
Investigated diseases:
- Glycogen storage disease type II
Investigated drugs:
- Avalglucosidase Alfa
Study on Trastuzumab Deruxtecan and Fluorouracil for Patients with HER2-Positive Gastric or Gastroesophageal Cancer with Minimal Residual Disease

Recruiting

2 1 1 1
Investigated diseases:
- Gastric cancer
- Gastrooesophageal cancer
Investigated drugs:
Study on Axial Spondyloarthritis Treatment Using Technetium-Labeled Certolizumab Pegol for Patients with Axial Spondyloarthritis

Recruiting

3 1 1
Investigated diseases:
- Axial spondyloarthritis
Investigated drugs:
- Technetium (99Mtc) Certolizumab Pegol
Study on Esketamine for Treating Chronic Pain in Endometriosis Patients

Recruiting

3 1 1
Investigated diseases:
- Endometriosis
Investigated drugs:
Study of Nipocalimab in Pregnant Women at Risk of Severe Hemolytic Disease of the Fetus and Newborn (HDFN)

Recruiting

3 1
Investigated diseases:
- ABO haemolytic disease of newborn
Investigated drugs:
- Nipocalimab
+5
Study on Dapagliflozin for Reducing Atrial Fibrillation and Kidney Injury in Patients Awaiting Coronary Artery Bypass Surgery

Recruiting

3 1 1
Investigated diseases:
Investigated drugs:
- Dapagliflozin
Study on Gene Therapy with AAV9.LAMP2B for Male Patients with Danon Disease

Recruiting

2 1 1 1
Investigated diseases:
- Glycogen storage disease type II
Investigated drugs:
Study on Coronary Artery Disease: Evaluating Myocardial Blood Flow Using SYN2, Regadenoson, and Adenosine in Patients with Heart Conditions

Recruiting

2 1 1 1
Investigated diseases:
- Coronary artery disease
Investigated drugs:
Study on Long-term Safety and Efficacy of Efgartigimod PH20 SC in Adults with Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)

Recruiting

2 1 1
Investigated diseases:
- Chronic inflammatory demyelinating polyradiculoneuropathy
Investigated drugs:
- Efgartigimod Alfa
+5

Full Name *

e-Mail *

Country Prefix *

Phone Number *

Nationality *

Gender *

Check all consents

Check all consents

I accept the Terms and Conditions and Privacy Policy *

*I accept the Terms and Conditions and Privacy Policy

I consent to receiving commercial information from the Service Operator *

*I consent to receiving commercial information from the Service Operator

I consent to the use of telecommunications terminal equipment and automated calling systems by the Service Operator for marketing communication purposes *

*I consent to the use of telecommunications terminal equipment and automated calling systems by the Service Operator for marketing communication purposes

We use cookies